Introduction
A speci®c translocation between chromosomes 11 and 22 is found in 85% of Ewing's sarcomas and peripheral primitive neuoroectodermal tumors (pPNET) of childhood (Delattre et al., 1992; Turc-Carel et al., 1988) . Molecular analyses have shown that this rearrangement fuses the N-terminus of the EWS gene to the Cterminus of the FLI1 gene, creating a chimeric transcript, and ultimately a fusion protein (Delattre et al., 1992) . The resultant EWS/FLI1 fusion protein has the biochemical characteristics of an aberrant transcription factor (Baily et al., 1994; Braun et al., 1995; Lessnick et al., 1995; May et al., 1993a,b; Ohno et al., 1993) . EWS/FLI1 can act as an oncogene. NIH3T3 cells expressing the EWS/FLI1 protein form colonies in soft agar and tumors in immune de®cient mice May et al., 1993a May et al., ,b, 1997 . Although forced expression of EWS/FLI1 in NIH3T3 cells results in increased transformation potential, some cell lines are resistant to this eect even though they can be transformed by other oncogenes. YAL-7, a subclone of NIH3T3, tolerates forced expression of EWS/FLI1 but cannot grow anchorage-independently in soft agar. However, overexpression of EWS/FLI1 appears to be toxic in RAT-1 ®broblasts (Lessnick, 1994) , NCM-1 neural progenitors, and CTR rhabdomyosarcoma cells (Braun, 1997) . These ®ndings suggest that the cellular context of EWS/FLI1 expression may in¯uence its transforming ability. One possible explanation for this dierence in biologic response is that EWS/FLI1 could be regulating dierent sets of target genes in dierent cell lines. Alternatively, genes present in one cell type and not in another may synergize or antagonize the eects of EWS/FLI1. This second possibility could oer a system from which key EWS/FLI1 target genes could be elucidated.
To help identify transformation-related EWS/FLI1 targets, Representational Dierence Analysis (RDA) was employed to ®nd dierentially expressed genes between a transformed line, NIH3T3 expressing EWS/ FLI1, and a nontransformed line, YAL-7 EWS/FLI1. Thirteen unique cDNA fragments derived from dierentially expressed genes were found by this screening technique. Here, we focus on the up regulated expression of one of these genes, murine E2-C (mE2-C).
mE2-C is the ortholog of a human cyclin speci®c ubiquitin conjugating enzyme, E2-C/UbcH10 (Townsely et al., 1997) . Biochemical studies have shown that UbcH10 is involved in two processes: inactivation of cdc2, by destruction of the mitotic cyclins; and anaphase onset, by destruction of one or more proteins that maintain sister chromatid cohesion (Townsely et al., 1997) . Destruction of cyclin B, a UbcH10 substrate, is essential for exit from mitosis and entry into G1 of the next cycle (reviewed in Murray, 1995) . Thus, the function of UbcH10 is closely linked to the progression of cells through M phase. Tumor cells often acquire alterations to genes that directly regulate the cell cycle (reviewed in Sherr, 1996) . Up regulation of mE2-C by the EWS/FLI1 oncoprotein represents another potential pathway where cellular transformation could impact on cell cycle regulation.
Results

RDA identi®es genes that are dierentially expressed between transformed and nontransformed cells expressing EWS/FLI1
While EWS/FLI1 is able to transform NIH3T3 cells in a single step fashion, some cell lines are resistant to this eect. In particular, when EWS/FLI1 is stably expressed in YAL-7, an NIH3T3 subclone, no colonies form in soft agar (Figure 1a ). This is in contrast to the eect of activated RAS, which is capable of transforming both NIH3T3 and YAL-7 cells. A Western blot was used to con®rm that equal levels of EWS/FLI1 protein were expressed in these two transfected populations (Figure 1b) . This suggests that genes induced by EWS/FLI1 in NIH3T3 cells could dier from those modulated by EWS/FLI1 in YAL-7 cells.
RDA was used to ®nd genes that were dierentially expressed between these two cell populations. Amplicons were generated from cDNA prepared from polyclonal populations of NIH3T3 cells or YAL-7 cells stably expressing EWS/FLI1. Both 3T3 EWS/ FLI1 minus YAL-7 EWS/FLI1 and the reciprocal YAL-7 EWS/FLI1 minus 3T3 EWS/FLI1 comparisons were performed. After two rounds of RDA, subtracted cDNA fragments were randomly cloned into plasmids and individual clones were tested. Duplicate colony ®lters were probed with radiolabeled starting amplicons. Those clones that showed dierential hybridization were further analysed.
cDNA fragments from a total of 13 dierentially expressed genes were isolated (Table 1 ). The dierential expression of all of these genes was con®rmed by Northern analyses using RNA harvested from the starting cell populations. The YAL-7 EWS/FLI1 minus 3T3 EWS/FLI1 comparison yielded more dierentially expressed gene fragments. For the most part, these genes encode structural proteins that are not up regulated by EWS/FLI1 but were expressed at higher levels in YAL-7 cells over NIH3T3 cells. In contrast, the 3T3 EWS/FLI1 minus YAL-7 EWS/FLI1 RDA resulted in three dierentially expressed transcripts. Figure 2 ) (Townsely et al., 1997; Yu et al., 1996) .
Northern blots using the 1C47 RDA fragment con®rmed dierential expression between 3T3 EWS/ FLI1 and YAL-7 EWS/FLI1 cell lines (Table 1 and Figure 6 ). In addition, mE2-C was upregulated by EWS/FLI1 in NIH3T3 (Figure 3a) but not in NIH3T3 parental cells. Immunoblots using antisera raised against bacterially expressed murine E2-C detected a similar increase in mE2-C protein level in EWS/FLI1 expressing NIH3T3 cells ( Figure 3b ). An inducible system was used to determine when mE2-C is up regulated in relation to EWS/FLI1 expression. Increase in mE2-C transcripts was ®rst detected after 12 h of treatment with Zn +2 and reached steady state levels within 24 h (Figure 4 ).
Cyclic expression of E2-C is maintained in EWS/FLI1 transformed cells
E2-C/UbcH10 is thought to play a critical role in the regulation of cyclin B during the cell cycle (Townsely et al., 1997) . To determine if mE2-C is cyclically . By contrast, induction of EWS/ FLI1 target genes has varied from as early as 4 ± 8 h in the case of stromelysin-1 to the 8 ± 12 h seen with E2-C Figure 2 Alignment of the amino acid sequences of human and murine E2-C. Murine E2-C (mE2-C) shows 96% amino acid identity to Human E2-C (UbcH10). X's designate amino acids that are dierent between the two sequences, and the bold C indicates the catalytically active cysteine residue EWS/FLI1 up regulates mE2-C A Arvand et al regulated, mE2-C transcript and protein levels were assayed at dierent points in the cell cycle. Polyclonal populations of NIH3T3 cells with and without EWS/ FLI1 were synchronized in G0/G1. After release from G0/G1, cells were harvested at dierent time points and assayed for mE2-C expression. FACS analyses was performed to assure that the proportion of cells in G1, S and G2/M phases in the NIH3T3 and EWS/FLI1 transformed NIH3T3 cell populations were approximately equal for each time point.
In both the transformed and untransformed NIH3T3 cells, mE2-C expression is dramatically low in G0 arrested cells, and then progressively rises as cells transit into S phase (Figure 5 ). At the time of G0 release, mE2-C transcript is detected in both cell populations but no mE2-C protein is evident. However at each time point thereafter, the levels of both mE2-C transcript and protein were higher in the EWS/FLI1 transformed cells than in the untransformed NIH3T3 cells.
E2-C is up regulated by other transforming genes in NIH3T3 cells
In order to test whether mE2-C up regulation was speci®c to transformation by EWS/FLI1, mE2-C expression was assessed in NIH3T3 cells transformed by other unrelated genes. Stable polyclonal NIH3T3 populations expressing one of a number of transforming genes were generated. For each population, the functional expression of each gene was con®rmed by the ability to induce growth of macroscopic colonies in soft agar. mE2-C transcription was elevated in cells expressing activated cdc42, v-ABL, and c-MYC though the amount of mE2-C induction was less than that seen by EWS/FLI1 (Figure 6 ). In distinction to these genes, overexpression of activated RAS had little eect on mE2-C transcript levels. In contrast to the eect seen with EWS/FLI1, cdc42 and c-MYC up regulated mE2-C in YAL-7 cells to a similar degree as that seen in NIH3T3 cells.
We have also examined mE2-C expression in transforming variants of EWS/FLI1. mE2-C transcripts were increased in NIH3T3 cells expressing EWS/ERG, an alternate chimeric protein found in about 5% of Ewing's sarcomas; and TLS/FLI1, an arti®cial fusion utilizing the N-terminus of TLS, a close structual homolog to EWS (data not shown).
E2-C accelerates cyclin B degradation in a mammalian cell free system E2-C has been shown to be a key regulator in cyclin B degradation that is required for the G2/M transition in the cell cycle. Introduction of a dominant negative E2-C/UbcH10 results in cell cycle arrest (Townsely et al., 1997) . Up regulation of E2-C during oncogenic transformation may enhance the degradation of cyclin B. This in turn could accelerate progression through mitosis and promote cell growth.
A cell free system was used to assess the eect of increasing mE2-C protein concentration on cyclin B levels ( Figure 7) . Extracts from HeLa cells synchronized in G1 were prepared and mixed with radiolabeled in vitro translated cyclin B. Cyclin BDD (deleted D Box) that cannot be degraded by the components of ubiquitin pathway was used as control for speci®city of mE2-C activity. Buer blank or bacterially expressed Western blot analysis of the corresponding time points. mE2-C protein is undetectable at hour 0 and remains low until 21 h after release from G0 in NIH3T3. In the transforming line, mE2-C protein is also undetectable at hour 0 but progressively rises starting with the hour 10 time point. As with mE2-C transcripts, for each time point mE2-C protein expression is higher in EWS/ FLI1 transformed NIH3T3 cells than in the parent NIH3T3 cells Figure 6 mE2-C expression in NIH3T3 and YAL-7 cells containing selected transforming genes. Northern blots using RNA from NIH3T3 or YAL-7 polyclonal cell lines stably expressing each gene, were hybridized to mE2-C and b-actin probes. Signals were detected by phosphoimager and the amount of mE2-C transcript was quantitated with respect to b-actin for each sample. In NIH3T3 cells, mE2-C transcript is up regulated almost ®vefold by EWS/FLI1; approximately 2 ± 3-fold by cdc42, c-MYC, and v-ABL; and to no apparent extent by RAS. By contrast, EWS/FLI1 does not up regulate mE2-C in YAL-7 cells. Allowing for slight variation, YAL-7 cells expressing cdc42, c-MYC and RAS expressed similar levels of mE2-C transcript as their NIH3T3 counterparts EWS/FLI1 up regulates mE2-C A Arvand et al mE2-C protein was then added, and samples were taken at varying time points to be assayed for the presence of cyclin B by SDS ± PAGE followed by autoradiography. Using buer blank alone, Cyclin B was undetectable after a 180 min time period. This con®rms that the mitotic cyclin destruction machinery remains active in G1 (Brandeis and Hunt, 1996) . Addition of puri®ed murine E2-C to the reaction mixture accelerated the destruction of cyclin B approximately threefold. This result demonstrates that murine E2-C is functionally equivalent to UbcH10, and also argues that E2-C is a rate limiting component of the mitotic cyclin destruction machinery. In contrast to this, addition of dominant negative form of mE2-C with a point mutation in the cysteine active site greatly retarded cyclin B destruction. This result further con®rms identi®cation of the EWS/FLI1 regulated Ubc as a functional UbcH10 ortholog.
Discussion
Our initial goal was to compare gene expression in cells that are transformable and nontransformable by EWS/ FLI1. For the most part, we recovered genes that were dierentially expressed between the parental NIH3T3 and YAL-7 cell lines and were frequently not modulated by EWS/FLI1. This suggests that the dierence in growth in soft agar between NIH3T3 cells expressing EWS/FLI1 and YAL-7 cells expressing EWS/FLI1 may be due not only to dierences in EWS/ FLI1 induced genes but also to inherent genetic factors that may complement or antagonize the transforming eect of EWS/FLI1. In this regard, it is notable that TIMP-3 is expressed in YAL-7 but not in NIH3T3 cells (Table 1) . TIMP-3 stoichiometrically binds and inhibits stromelysin-1, a metalloproteinase that is associated with enhanced tumorigenicity and is up regulated by EWS/FLI1 both in NIH3T3 and YAL-7 cells (Apte et al., 1995; Braun et al., 1995) (Table 1) . Clearly, some genes are up regulated by EWS/FLI1 in NIH3T3 cells but not in YAL-7. Expression of ribosomal L26, a gene up regulated in murine macrophages by in¯ammatory mediators, is modestly increased by EWS/FLI1 only in NIH3T3 cells (Segade et al., 1995) . Similarly in NIH3T3 cells, EWS/FLI1 increased transcription of RACK1, a gene of unknown function that binds to protein kinase C (Ron et al., 1995) . However, steady state protein levels of RACK1 do not change in NIH3T3 cells with EWS/FLI1 expression (data not shown). These data indicate that RDA is a powerful screening tool that can isolate genes that are dierentially expressed as little as ®vefold and bear the potential for biological signi®cance.
mE2-C is up regulated by EWS/FLI1 both at the transcript and protein level. There is an approximate 10 h pause between induction of EWS/FLI1 expression and increase in mE2-C mRNA, suggesting that EWS/ FLI1 does not modulate mE2-C expression directly but probably through other signaling intermediates. Assessing mE2-C expression in NIH3T3 cells at varying times after G0 release suggests that mE2-C may be regulated throughout the cell cycle. This pattern of expression of mE2-C is maintained in NIH3T3 EWS/FLI1 cells but is enhanced. For each time point, mE2-C transcript and protein is higher in the transformed cells. Interestingly, mE2-C transcripts are evident in G0 arrested NIH3T3 and NIH3T3 EWS/FLI1 cells when mE2-C protein expression is undetectable. This suggests that mE2-C may also be regulated post-transcriptionally at least under certain growth conditions.
In our cell free system, the lysates have endogenous capability for degrading cyclin B. Addition of exogenous mE2-C accelerates cyclin B destruction suggesting that mE2-C is rate limiting for the degradation of cyclin B in vitro. While there appears to be an inverse relationship between cyclin B and mE2-C levels in vitro, the eects of mE2-C over expression in vivo are less clear. Forced expression of either EWS/FLI1 or mE2-C in NIH3T3 cells does not grossly alter their cell cycle pro®le or steady state cyclin A or B protein levels (data not shown). To a certain extent this may re¯ect the technical challenge of measuring the G2/M transition. Cells normally spend a short time at this point in the cell cycle and trying to assess any reduction in this interval is dicult. This apparent lack of an in vivo response to E2-C may also be due to the use of adherent cultures in all our assays. While EWS/FLI1 transformed cells are clearly more proli®c in nonadherent conditions (soft agar), when grown on plastic, the dierences in growth rate between EWS/FLI1 and parent NIH3T3 cells is much less apparent. Accurate assessment of the in vivo eects of E2-C up regulation may require further technical development to measure cell cycle parameters in cells grown under nonadherent conditions that are as stringent as our soft agar assay.
The increase in mE2-C by EWS/FLI1 and other oncogenes, may re¯ect a general up regulation of genes needed for cell cycle progression. Additionally, the presence of higher than normal levels of mE2-C during mitosis could lead to increases in the rates of ubiquitin-dependent proteolysis of both mitotic cyclins as shown here, and in the destruction of other proteins that regulate anaphase onset and sister chromosome separation later in mitosis (Cohen et al., 1996; Funabiki et al., 1996; Guacci et al., 1997; Juang et al., 1997; Michaelis et al., 1997; Stratmann et al., 1996) . Imbalances in the rates of these normally coordinated processes could contribute to conditions that promote aneuploidy.
While the potential eects of mE2-C overexpression could promote deregulated cell growth, they are not sucient for transformation. NIH3T3 cells stably expressing a mE2-C transgene do not form colonies in soft agar (data not shown). While the eect of cdc42, c-MYC and RAS on mE2-C expression in NIH3T3 and YAL-7 cells was similar, there was a signi®cant dierence in mE2-C induction by EWS/FLI1 in these two cellular backgrounds. It is possible that this dierential eect on mE2-C is partially responsible for the ability of EWS/FLI1 to transform NIH3T3 cells. However, overexpression of E2-C in YAL-7 cells is not sucient to render them transformable by EWS/FLI1 (data not shown). This suggests that other gene products in addition to mE2-C, must also play important roles in transformation. Though cdc42, c-MYC and v-ABL appear to up regulate mE2-C, RAS is able to transform NIH3T3 cells without any apparent eect on mE2-C expression level. This suggests that there could be multiple pathways to transform cells and while up regulation of mE2-C may be a common event in transformation, it is not obligatory.
Materials and methods
Cell lines and tissue culture
NIH3T3 cells and YAL-7 parental lines as well as cells with EWS/FLI1, activated cdc42, c-myc, activated RAS and v-abl were grown in Dulbecco's Modi®ed Eagle Media (DMEM) with 5% calf serum supplemented with glutamine. Helper-free retroviral stocks were prepared as previously described (May et al., 1993a) . Cell lines expressing the genes listed were prepared by infection with appropriate viral stocks. Cells containing the retroviral constructs were selected with G418 for approximately 7 ± 10 days. Transformation was assessed by formation of colonies in soft agar (May et al., 1993a) . 12.7 is the cell line containing a Zn 2+ inducible EWS/FLI1 construct. A full length EWS/FLI1 cDNA was placed under the transcriptional control of the ovine metallothionein promoter in the vector pMTCB6+ and transfected into NIH3T3 cells as described previously .
Northern and Western blots
RNA and protein was harvested from retrovirally infected NIH3T3 and YAL-7 cells lines immediately after antibiotic selection. Total RNA were made from lysates using STAT-60 reagent (TEL-TEST, Inc.) according to manufacturer's recommendations and employed in Northern experiments as previously described (May et al., 1993a) . In parallel, protein lysates were prepared by lysing the cells in 0.5% NP-40 lysis buer (50 mM Tris, 300 mM NaCl, 10% glycerol, 1 mM EDTA). Protein concentration were determined by Bradford Assay. 30 mg of protein was loaded for each cell line, equal loading was con®rmed by Coomassie staining the SDS gels. For EWS/FLI1 detection FLI1 antibody was used as a primary Santa Cruz Biotechnology, Inc).
RDA subtraction and screening
Total RNA was harvested from polyclonal NIH3T3 EWS/ FLI1 and YAL-7 EWS/FLI1 stably transfected cell lines. Two rounds of subtractive hybridization were performed in both directions: 3T3 EWS/FLI1 minus YAL-7 EWS/FLI1 and YAL-7 EWS/FLI1 minus 3T3 EWS/FLI1. cDNA synthesis, amplicon preparation and subtractive hybridizations were performed as described previously . cDNA fragments after two rounds of subtraction in both directions were randomly cloned into pBluescript II KS + (Stratagene). Individual clones were then picked and placed into 96 well microtiter plates. Subsequently, duplicate colony ®lters were prepared from these cultures by stamping. The colony bound ®lters were lysed, baked and probed with radiolabled starting amplicons from either YAL-7 or 3T3. Dierentially hybridizing clones were identi®ed and further analysed by Northern analysis (May et al., 1993a) .
Cloning murine E2-C (mE2-C)
A Lambda ZapII cloning vector (Stratagene) was used to construct a cDNA library from NIH3T3 stably expressing EWS/FLI1 and screened as previously described (Thompson et al., 1996) . Primary phage were screened with the RDA-produced E2 cDNA fragment. Ten clones were identi®ed which ranged in size from 1.0 ± 1.6 kb. Selected clones were restriction digested, mapped and sequenced using the DNA Sequencing Kit (PE Applied Biosystems). Clone 22, which had the same approximate size as the E2 transcript, seen in Northern analysis, was completely sequenced. This clone contained a short 48 bp 5' untranslated region and a single open reading frame encoding 179 amino acids.
Bacterial expression and puri®cation of murine E2-C for antisera production
The pGEX-2T (Stratagene) expression system was used to create a GST-mE2-C fusion gene with the coding sequence of clone 22. A standard Glutathione Agarose separation scheme was used to purify the fusion protein from XL-1 Blue Escherichia coli (Smith and Johnson, 1988) . A rabbit mE2-C polyclonal antibody was generated using the puri®ed GST-mE2-C as immunogens (HRP Antisera Services).
Cell cycle synchronization and analysis
Polyclonal populations of 3T3 EWS/FLI1 and 3T3 were synchronized by a combination of serum deprivation and contact inhibition. 85 ± 90% of cells were arrested in G0/ G1 and DNA content was assessed with propidium iodide staining by FACS analysis (Ormerod, 1996) .
In vitro mutagenesis and clone isolation
A mutant mE2-C cDNA was created in a two step PCR process. The amino terminal portion of murine E2-C was ampli®ed from the full length cDNA clone in pBluescript SK using oligo SK (5'-GGCCGCTCTAGAACTAGTG-GAT) and oligo MECSR (5'-GATGTCCAGGCT-GATGTTGCC) PCR primers. Oligo MECSR contains a mutation at amino acid 114 that changes the cysteine active site to serine. The carboxy-terminal portion of mE2-C was ampli®ed using oligo KS (5'-CTCGAGGTCGACGG-TATCGATA) and oligo MECSF (5'-GGCAACAT-CAGCCTGGACATC) PCR primers. MECSF is the antisense sequence primer of MECSR and contains the same point mutation at the same nucleotide position. The EWS/FLI1 up regulates mE2-C A Arvand et al two PCR fragments containing the mutation were then allowed to anneal, and a full-length mE2-C mutant was generated by PCR ampli®cation using oligos SK and KS. mE2-C mutant was then subcloned into pBluescript SK and sequenced.
Cyclin B destruction assay
Wildtype and dominant negative His-tagged murine E2-C proteins were constructed using pQE-60 expression system (Qiagen). These proteins were expressed in E. coli BL21 (DE3) and puri®ed on Ni-NTA spin columns (Qiagen) following the manufacturer's instructions. After purification, the buer was exchanged to buer A (20 mM HEPES/ NaOH pH 7.5, 5 mM KCl, 1.5 mM MgCl 2 , 1 mM DTT) using gel®ltration on Sephadex G-25 columns (Pharmacia). The activity of recombinant murine E2-C proteins were assayed using an in vitro destruction assay derived from human tissue culture cells. Cell lysates derived from HeLa cells synchronized in G1 phase by a nocodazole block and release protocol were prepared in buer A (Li and Kelly, 1984) . The cell extracts were prepared, frozen in liquid nitrogen and stored at 7808C until used (Brandeis et al., 1996) . Destruction assays were performed in a ®nal volume of 10 ml. An ATP regenerating system (25 mM phosphocreatine, 1 mM ATP, 10 mg/ml creatine kinase) was added to 5 ml of cell extract followed by the addition of 1 ml 35 Smethionine labeled substrates (human cyclin B or cyclin BDD (1-86)). Recombinant E2-C proteins were added to a ®nal concentration of 2 mM and samples were taken at 0, 30, 60, 120 and 180 min. The radiolabelled substrates were prepared by a coupled in vitro transcription/translation reaction (TNT, Promega). Human cyclin B and cyclin BDD (1-86) were expressed from pGEM-4Z and pET5a, respectively (Yu et al., 1996) .
